Xilio Development Stock Market Value
| XLO Stock | USD 0.58 0.02 3.33% |
| Symbol | Xilio |
Will Biotechnology sector continue expanding? Could Xilio diversify its offerings? Factors like these will boost the valuation of Xilio Development. Anticipated expansion of Xilio directly elevates investor willingness to pay premium valuations. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Xilio Development data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Earnings Share (0.61) | Revenue Per Share | Quarterly Revenue Growth 7.425 | Return On Assets | Return On Equity |
The market value of Xilio Development is measured differently than its book value, which is the value of Xilio that is recorded on the company's balance sheet. Investors also form their own opinion of Xilio Development's value that differs from its market value or its book value, called intrinsic value, which is Xilio Development's true underlying value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Because Xilio Development's market value can be influenced by many factors that don't directly affect Xilio Development's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Xilio Development's value and its price as these two are different measures arrived at by different means. Investors typically determine if Xilio Development is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. Meanwhile, Xilio Development's quoted price indicates the marketplace figure where supply meets demand through bilateral consent.
Xilio Development 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Xilio Development's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Xilio Development.
| 11/17/2025 |
| 02/15/2026 |
If you would invest 0.00 in Xilio Development on November 17, 2025 and sell it all today you would earn a total of 0.00 from holding Xilio Development or generate 0.0% return on investment in Xilio Development over 90 days. Xilio Development is related to or competes with PDS Biotechnology, Actinium Pharmaceuticals, Tempest Therapeutics, OnKure Therapeutics, Kezar Life, Skye Bioscience, and Tvardi Therapeutics. Xilio Therapeutics, Inc., a clinical-stage biotechnology company, develops immunotherapies to improve the immune system ... More
Xilio Development Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Xilio Development's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Xilio Development upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.16) | |||
| Maximum Drawdown | 15.41 | |||
| Value At Risk | (5.56) | |||
| Potential Upside | 4.23 |
Xilio Development Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Xilio Development's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Xilio Development's standard deviation. In reality, there are many statistical measures that can use Xilio Development historical prices to predict the future Xilio Development's volatility.| Risk Adjusted Performance | (0.10) | |||
| Jensen Alpha | (0.49) | |||
| Total Risk Alpha | (0.70) | |||
| Treynor Ratio | (0.86) |
Xilio Development February 15, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | (0.10) | |||
| Market Risk Adjusted Performance | (0.85) | |||
| Mean Deviation | 2.3 | |||
| Coefficient Of Variation | (719.94) | |||
| Standard Deviation | 3.26 | |||
| Variance | 10.62 | |||
| Information Ratio | (0.16) | |||
| Jensen Alpha | (0.49) | |||
| Total Risk Alpha | (0.70) | |||
| Treynor Ratio | (0.86) | |||
| Maximum Drawdown | 15.41 | |||
| Value At Risk | (5.56) | |||
| Potential Upside | 4.23 | |||
| Skewness | 0.4447 | |||
| Kurtosis | 2.47 |
Xilio Development Backtested Returns
Xilio Development shows Sharpe Ratio of -0.0958, which attests that the company had a -0.0958 % return per unit of risk over the last 3 months. Xilio Development exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please check out Xilio Development's Mean Deviation of 2.3, market risk adjusted performance of (0.85), and Standard Deviation of 3.26 to validate the risk estimate we provide. The firm maintains a market beta of 0.54, which attests to possible diversification benefits within a given portfolio. As returns on the market increase, Xilio Development's returns are expected to increase less than the market. However, during the bear market, the loss of holding Xilio Development is expected to be smaller as well. At this point, Xilio Development has a negative expected return of -0.3%. Please make sure to check out Xilio Development's treynor ratio, accumulation distribution, as well as the relationship between the Accumulation Distribution and price action indicator , to decide if Xilio Development performance from the past will be repeated at some point in the near future.
Auto-correlation | 0.84 |
Very good predictability
Xilio Development has very good predictability. Overlapping area represents the amount of predictability between Xilio Development time series from 17th of November 2025 to 1st of January 2026 and 1st of January 2026 to 15th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Xilio Development price movement. The serial correlation of 0.84 indicates that around 84.0% of current Xilio Development price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.84 | |
| Spearman Rank Test | 0.77 | |
| Residual Average | 0.0 | |
| Price Variance | 0.0 |
Pair Trading with Xilio Development
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Xilio Development position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Xilio Development will appreciate offsetting losses from the drop in the long position's value.Moving together with Xilio Stock
Moving against Xilio Stock
| 0.83 | DRTS | Alpha Tau Medical | PairCorr |
| 0.82 | 6C1 | CytomX Therapeutics | PairCorr |
| 0.75 | EQ | Equillium | PairCorr |
| 0.71 | DSGN | Design Therapeutics | PairCorr |
| 0.69 | DNTH | Dianthus Therapeutics | PairCorr |
The ability to find closely correlated positions to Xilio Development could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Xilio Development when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Xilio Development - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Xilio Development to buy it.
The correlation of Xilio Development is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Xilio Development moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Xilio Development moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Xilio Development can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Xilio Development Correlation, Xilio Development Volatility and Xilio Development Performance module to complement your research on Xilio Development. To learn how to invest in Xilio Stock, please use our How to Invest in Xilio Development guide.You can also try the Stocks Directory module to find actively traded stocks across global markets.
Xilio Development technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.